💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Clovis Oncology, Inc. (CLVS)
« Back to company indexCLVS Chatter Timeline
Stock Ticker for CLVS
Most Active Tweeters for CLVS
| User | Tweets |
|---|---|
| @Tickeron | 21 |
| @TheTradingDesk1 | 13 |
| @LeaferBlue | 12 |
| @kingkappital | 9 |
| @PennySearch | 5 |
Recent Tweets for CLVS
 |
@invescent $CLVS Data indicates that the overall analyst sentiment for CLVS is neutral Simplify the way you research stocks… https://t.co/RtijbeyWbH 3:01am |
 |
@LeaferBlue $CLVS Dear Ginger Graham: please initiate a BOD vote to fire Pat Mahaffy. I think the cause should be clear by now. 3:01am |
 |
@kingkappital $SRRA today 60% $CLVS will have 300-400-1000% day/week.. January 25th 2022, 7:01pm |
 |
@BiotechDablam $clvs I think that for him, selling shares is the core of the business. January 25th 2022, 2:01pm |
|
@BiotechDablam $clvs Has the CEO resigned or fired? It is the question that every shareholder asks himself at the beginning of the… https://t.co/LRggsfc07B January 25th 2022, 2:01pm |
 |
@Tickeron $CLVS's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/cX0apPgH1c January 25th 2022, 2:01pm |
|
@Tickeron Good move or bad move? $CLVS Aroon Indicator entered a Downtrend. #ClovisOncology https://t.co/RPnC8hBrqd https://t.co/ZeLITdbRyk January 25th 2022, 2:01pm |
|
@Tickeron How does this affect your portfolio? $CLVS RSI Indicator left the oversold zone. #ClovisOncology… https://t.co/DM85Bdvuo5 January 25th 2022, 1:01pm |
|
@LeaferBlue $CLVS since Mahaffy’s best talent is lying, he should tell just one more fib to juice his stock price. How’s 95% OR… https://t.co/GRZbRy9qmG January 24th 2022, 10:01pm |
|
@LeaferBlue $CLVS another calendar year, another dismal effort by the notoriously corrupt Mahaffy and his do nothing board of d… https://t.co/46VA6fR2RC January 24th 2022, 10:01pm |
 |
@TheTradingDesk1 $CLVS CEO enjoying that multi-7-figure salary while his shareholders beg for some kibble at the side of the table f… https://t.co/s1SZBOVnV4 January 24th 2022, 8:01pm |
|
@kingkappital @Mastertrader777 Buy $clovis bro $clvs … too chocolate January 24th 2022, 8:01pm |
 |
@khmerxbxboi Like if you still bullish on $CLVS in this bleeding #stockmarkets https://t.co/6Y4ZlGX4tV January 24th 2022, 8:01pm |
|
@Liborprivate $CLVS this is ridiculously undervalued January 24th 2022, 7:01pm |
|
@kingkappital RT @kingkappital: How $CLVS is gonna look https://t.co/VvUx9yOKyc January 24th 2022, 6:01pm |
 |
@lqqkerinsider $CLVS Not worth investing here yet. Wait for another capital raise and their first R/S. https://t.co/wJn57qSPyM January 24th 2022, 1:01am |
|
@kingkappital @LasseNJohansen I’m not. But it’s great & it will move in unison w $clvs most likely January 23rd 2022, 6:01pm |
|
@Tickeron $CLVS enters a Downtrend because Momentum Indicator dropped below the 0 level on January 18, 2022. View odds for th… https://t.co/bHM0sgrtI7 January 23rd 2022, 5:01pm |
|
@kingkappital Last time I touched $clvs it squeezed from 3 to 16 in a week https://t.co/bsOi2gBIJq January 23rd 2022, 4:01pm |
|
@TheTradingDesk1 @kingkappital $CLVS is more like the Jets or Jags. January 23rd 2022, 4:01pm |
|
@kingkappital How $CLVS is gonna look https://t.co/VvUx9yOKyc January 23rd 2022, 2:01pm |
|
@Tickeron $CLVS enters a Downtrend as Momentum Indicator dropped below the 0 level on January 18, 2022. View odds for this an… https://t.co/4nrSV06VTH January 22nd 2022, 7:01am |
|
@Tickeron Is this good for your portfolio? $CLVS Aroon Indicator entered a Downtrend. #ClovisOncology https://t.co/e4tnLEEjSN https://t.co/WPunE0etMe January 22nd 2022, 7:01am |
|
@Tickeron A.I.dvisor made a bearish call on $CLVS, netting in a 19.19% gain over 3 weeks #ClovisOncology… https://t.co/8LPoWjromc January 22nd 2022, 6:01am |
|
@kingkappital $CLVS in a few months we gonna laugh at 2s https://t.co/Xs7fUiWVFk January 22nd 2022, 5:01am |
|
@LeaferBlue @TheTradingDesk1 One way or another Pat has to leave, even an amateur could do better to generate value from $CLVS.… https://t.co/lOKTkPeovi January 22nd 2022, 5:01am |
|
@TheTradingDesk1 $CLVS Employees look to be boiling over just as much, if not more than investors. Degenerate Serial Diluter CEO w… https://t.co/Kj6aJaneoY January 22nd 2022, 3:01am |
 |
@ShogunTrade $CLVS Day Trading Ideas | 9 Trades executed,win rate of 77% and Profit Factor of 8. Check out the 15min chart. https://t.co/CBszvFAJFg January 21st 2022, 10:01pm |
|
@kingkappital $CLVS this is how you get generational wealth ?? January 21st 2022, 7:01pm |
|
@LeaferBlue $CLVS Mahaffy is creating the cancer within his company. There is no treatment here. He’s a criminal CEO scamming i… https://t.co/mJZ4Q5hQsb January 21st 2022, 6:01pm |
|
@Tickeron $CLVS enters a Downtrend because Momentum Indicator dropped below the 0 level on January 18, 2022. View odds for th… https://t.co/zw1kxUsk2H January 21st 2022, 3:01pm |
|
@Tickeron Does this make you nervous? $CLVS Aroon Indicator entered a Downtrend. #ClovisOncology https://t.co/4aloMuo01c https://t.co/WSIr5d9Akl January 21st 2022, 3:01pm |
 |
@TradeWithAlerts Nice print for $CLVS Size: 456725 Price: 2.33 Amount: $1,064,169.25 Time: 1600 See more: https://t.co/rx9GTbxNcE Jo… https://t.co/l26hMyYe8i January 20th 2022, 9:01pm |
|
@Tickeron $CLVS's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/NbSUTGNOpm January 20th 2022, 6:01pm |
 |
@ShortAlgoKing $CLVS Day Trading Ideas | 9 Trades executed,win rate of 77% and Profit Factor of 8. 15-min chart by… https://t.co/uIInqdTHuN January 20th 2022, 6:01pm |
 |
@Rajt1111 Like I said $CLVS is too easy for shorts. The moment $XBI sells a bit, they drive it significantly lower… January 20th 2022, 5:01pm |
|
@Rajt1111 Shorts are in full control $CLVS . They are selling at every bid… they won’t let it go up…. Too comfortable of the position they are in… January 20th 2022, 5:01pm |
 |
@PinkSheetDenise RT @PinkSheetSutter: As we await the accelerated approval withdrawal hearing for $CLVS Makena, @PharmaPinkSheet looks back at the experienc… January 20th 2022, 3:01pm |
 |
@PinkSheetSutter As we await the accelerated approval withdrawal hearing for $CLVS Makena, @PharmaPinkSheet looks back at the experi… https://t.co/Dylbhwj4wb January 20th 2022, 1:01pm |
 |
@ShortAlgoTrades $CLVS Awaiting Buy Signal. Chart by https://t.co/jpmUt7BvVp https://t.co/fz4kTnYHrP January 20th 2022, 1:01pm |
|
@LeaferBlue $CLVS all you need to know: #VoteNoShareIncrease. Stop the criminal CEO and derelict BoD from eroding whatever value is left. January 20th 2022, 6:01am |
|
@LeaferBlue $CLVS what undeserving RSU awards will Clovis management grant to their failing team this February? Watch the actio… https://t.co/krRiyvUeq4 January 20th 2022, 4:01am |
|
@ShortAlgoTrades $CLVS Look at this! 9 Trades executed, trade Profitability of 77% and Profit Factor of 8. 15 minute chart https://t.co/aX4juKafXG January 20th 2022, 4:01am |
|
@LeaferBlue $CLVS when you have a CEO (Mahaffy) who can't manage his way out of a cardboard box you get these types of absurd v… https://t.co/8481vrAIEZ January 19th 2022, 10:01pm |
 |
@SenateBiPartisN FYI -Any $CLVS investor seriously concerned about unethical practice & lack of BOD fiduciary governance, should cal… https://t.co/cYnXmR99N8 January 19th 2022, 7:01pm |
|
@TheTradingDesk1 $clvs If I had to guess by all of the employee banter I'm reading, securities fraud case coming to a CEO and BOD near you. January 19th 2022, 4:01pm |
|
@TheTradingDesk1 $clvs Look like legal troubles are in sight for this CEO. Deserved. Should have released Athena, shareholders are… https://t.co/UFZP3RdUca January 19th 2022, 2:01pm |
 |
@shortablestocks $CLVS is short sale restricted for 2022-01-19. https://t.co/czjUyUeI7V January 19th 2022, 2:01pm |
 |
@VatqLu $CLVS Waiting for Buy signal . https://t.co/cnpATROk3m January 19th 2022, 12:01pm |
|
@Tickeron $CLVS enters a Downtrend as Momentum Indicator dropped below the 0 level on January 18, 2022. View odds for this an… https://t.co/1i7zgVfba9 January 19th 2022, 9:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?